BTCC
/
BTCC Square
/
Global Cryptocurrency
/
Pharmaceutical Giant Adopts Most-Favored-Nation Pricing Amid Trump Tariff Threats
Pharmaceutical Giant Adopts Most-Favored-Nation Pricing Amid Trump Tariff Threats
18
3
BTCCSquare news:
Pfizer has become the first major pharmaceutical company to implement most-favored-nation pricing for the U.S. in response to President Trump's escalating tariff policies. The WHITE House has threatened a 100% tariff on branded pharmaceutical products unless manufacturers bring operations back to American soil.
Drug pricing disparities between the U.S. and Europe remain stark, driven by Medicare's historical inability to negotiate prices and complex supply chain markups. While the Inflation Reduction Act now permits limited Medicare negotiations, the system continues to favor higher list prices that account for middlemen cuts.
By:
